Couppis Maria H, Kennedy Craig H
Vanderbilt Kennedy Center, Vanderbilt University, Nashville, TN 37204, USA.
Psychopharmacology (Berl). 2008 Apr;197(3):449-56. doi: 10.1007/s00213-007-1054-y. Epub 2008 Jan 8.
Dopamine (DA) receptors within the nucleus accumbens (NAc) are implicated in the rewarding properties of stimuli. Aggressive behavior can be reinforcing but the involvement of NAc DA in the reinforcing effects of aggression has yet to be demonstrated.
To microinject DA receptor antagonists into the NAc to dissociate their effects on reinforcement from their effects on aggressive behavior and general movement.
Male Swiss Webster mice were implanted with guide cannulae aimed for the NAc and tested for aggressive behavior in a resident-intruder procedure. Aggressive mice were then conditioned on a variable-ratio 5 (VR-5) schedule with presentation of the intruder as the reinforcing event. The D1- and D2-like receptor antagonists SCH-23390 and sulpiride were microinfused (12-50 ng) before the mice responded on the VR-5 schedule and attacked the intruder. Open-field activity was also determined following the highest doses of these drugs.
SCH-23390 and sulpiride dose-dependently reduced VR responding but did not affect open-field activity. The 50-ng SCH-23390 dose suppressed response rates by 40% and biting behaviors by 10%; other aggressive behaviors were not affected. The 25 and 50 ng sulpiride doses almost completely inhibited VR responding; the 50-ng dose suppressed biting by 50%.
These results suggest that both D1- and D2-like receptors in the ventral striatum are involved in the rewarding properties of aggression, but that D1-like receptors may be related to the motivation to earn reinforcement as opposed to aggressive behavior.
伏隔核(NAc)内的多巴胺(DA)受体与刺激的奖赏特性有关。攻击行为可以是强化性的,但NAc多巴胺在攻击强化作用中的参与尚未得到证实。
向NAc微量注射DA受体拮抗剂,以区分其对强化作用的影响与对攻击行为和一般运动的影响。
将雄性瑞士韦伯斯特小鼠植入针对NAc的引导套管,并在定居者-入侵者程序中测试其攻击行为。然后,将攻击性小鼠按照可变比率5(VR-5)的时间表进行训练,将入侵者的出现作为强化事件。在小鼠按照VR-5时间表做出反应并攻击入侵者之前,微量注射D1和D2样受体拮抗剂SCH-23390和舒必利(12-50纳克)。在给予这些药物的最高剂量后,还测定了旷场活动。
SCH-23390和舒必利剂量依赖性地降低了VR反应,但不影响旷场活动。50纳克的SCH-23390剂量使反应率降低了40%,咬行为降低了10%;其他攻击行为未受影响。25和50纳克的舒必利剂量几乎完全抑制了VR反应;50纳克的剂量使咬行为降低了50%。
这些结果表明,腹侧纹状体中的D1和D2样受体都参与了攻击的奖赏特性,但D1样受体可能与获得强化的动机有关,而不是与攻击行为有关。